A A Carr

Preclinical characterization of the potential of the putative atypical antipsychotic MDL 100,907 as a potent 5-HT2A antagonist with a favorable CNS safety profile.

John H. Kehne, B M Baron, A A Carr et al. · Journal of Pharmacology and Experimental Therapeutics · 1996 · 358 citations · Full text

Financial cost as an obstacle to hypertension therapy.

Neil Shulman, Belkis Y. Martinez, D Brogan et al. · American Journal of Public Health · 1986 · 120 citations · Full text

Hypertension, Health Care Disparity, Health Disparities +20

[3H]MDL 100,907: a novel selective 5-HT2A receptor ligand

MichaelP. Johnson, BarryW. Siegel, A A Carr · Naunyn-Schmiedeberg s Archives of Pharmacology · 1996 · 79 citations

Functional Selectivity, Medicine, Receptor (Biochemistry) +3

Hemodynamic and Renal Effects of a Prostaglandin, PGA1, in Subjects with Essential Hypertension

A A Carr · The American Journal of the Medical Sciences · 1970 · 74 citations

Metabolic Syndrome, Hypertension, Renal Effects +13

Detection of hypertensive left ventricular hypertrophy.

A A Carr, L. Michael Prisant, Laurence O. Watkins · Hypertension · 1985 · 46 citations · Full text

Hypertension, Heart Failure, Adverse Cardiovascular Events +16